Spontaneous rupture of the spleen in AL amyloidosis

American Journal of Hematology

Volumn 74, Issue 2, 2003, Pages 131-135

  Oran, B ^a   Wright, D G ^a,b   Seldin, D C ^a,b   McAneny, D ^a   Skinner, M ^a,b   Sanchorawala, Vaishali ^a,b,c  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

AL amyloidosis; Splenectomy; Stem cell transplantation

Indexed keywords

FUROSEMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; PENICILLIN G; SPIRONOLACTONE;

ADULT; AL AMYLOIDOSIS; AMYLOIDOSIS; ARTICLE; AUTOTRANSPLANTATION; BLOOD CLOTTING FACTOR 10 DEFICIENCY; CASE REPORT; CLINICAL FEATURE; CONVALESCENCE; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY AMYLOIDOSIS; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SPLEEN RUPTURE; SPLENECTOMY; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; SYMPTOM;

AMYLOIDOSIS; FACTOR X DEFICIENCY; FEMALE; HUMANS; MALE; MIDDLE AGED; RUPTURE, SPONTANEOUS; SPLEEN;

EID: 0141618360     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10389     Document Type: Article

References (41)

1. Glenner GG, Terry W, Harada M, Isersky C, Page D. Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science 1971;172:1150-1151.
2. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45-59.
3. Solomon A, Frangione B, Franklin EC. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda). J Clin Invest 1982;70:453-460.
4. Kyle RA, Linos A, Beard CM, et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 1992;79:1817-1822.
5. Barth WF, Glenner GG, Waldmann TA, Zelis RF. Primary amyloidosis. Ann Intern Med 1968;69:787-805.
6. Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine (Baltimore) 1975;54:271-299.
7. Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc 1983;58:665-683.
8. Sanchorawala V, Wright DG, Seldin DC, et al. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transpl 2001;28:637-642.
9. Hyun BH, Varga CF, Rubin RJ. Spontaneous and pathologic rupture of the spleen. Arch Surg 1977;104:652-657.
10. Debnath D, Valerio D. Atraumatic rupture of the spleen in adults. R Coll Surg Edinb 2002;47:437-445.
11. Lewis SM, Swirsky D. The spleen and its disorders. In: Weatherall DJ, Ledingham JGG, Warrell DA editor. Oxford textbook of medicine, 3rd ed. Oxford: Oxford University Press; 1996.
12. Gertz MA, Kyle RA, Greipp PR. Hyposplenism in primary systemic amyloidosis. Ann Intern Med 1983;98:475-477.
13. King FH, Oppenheimer GD. Rupture of amyloid spleen. Ann Intern Med 1948;29:374-378.
14. Wiley AT, Teeter RR, Schnabel TG Sr. Rupture of the spleen in primary amyloidosis: report of a case. Med Clin North Am 1951;35:1841-1847.
15. Drapiewski JF, Sternileb SB, Jones R. Primary amyloidosis with spontaneous rupture of the spleen and sudden death. Ann Intern Med 1955;43:406-412.
16. Barth WF, Glenner GG, Waldmann TA, Zelis TF. Primary amyloidosis. Ann Intern Med 1968;69:787-805.
17. Polliack A, Hershko C. Spontaneous rupture of the spleen in amyloidosis. Isr J Med Sci 1972;8:57-60.
18. McMahon MJ, Lintott JD, Mair WS, Lee PW, Duthie JS. Occult rupture of the spleen. Br J Surg 1977;64:641-643.
19. Wilson H, Yawn DH. Rupture of the spleen in amyloidosis. JAMA 1979;241:790-791.
20. Hurd WW, Katholi RE. Acquired functional asplenia. Association with spontaneous rupture of the spleen and fatal spontaneous rupture of the liver in amyloidosis. Arch Intern Med 1980;140:844-845.
21. Lazerson J. Easy bruising but normal platelets in an old woman. Hosp Pract 1984;19:56A, 56B, 56F.
22. Okazaki K, Moriyasu F, Shiomura T, et al. Spontaneous rupture of the spleen and liver in amyloidosis - a case report and review of the literature. Gastroenterol Jpn 1986;21:518-524.
23. Kozicky OJ, Brandt LJ, Lederman M, Milcu M. Splenic amyloidosis: a case report of spontaneous splenic rupture with a review of the pertinent literature. Am J Gastroenterol 1987;82:582-587.
24. Russell TJ, Ferrera PC. Spontaneous rupture of an amyloid spleen in a patient on continuous ambulatory peritoneal dialysis. Am J Emerg Med 1998;16:279-280.
25. Sandberg-Gertzen H, Ericzon BG, Blomberg B. Primary amyloidosis with spontaneous splenic rupture, cholestasis, and liver failure treated with emergency liver transplantation. Am J Gastroenterol 1998;93:2254-2256.
26. Mumford AD, O'Donnell J, Gillmore JD, Manning RA, Hawkins PN, Laffan M. Bleeding symptoms and coagulation abnormal-ities in 337 patients with AL-amyloidosis. Br J Haematol 2000;110:454-460.
27. Dedi R, Bhandari S, Sagar PM, Turney JH. Delayed splenic rupture as a cause of haemoperitoneum in a CAPD patient with amyloidosis. Nephrol Dial Transplant 2001;16:2446.
28. Nowak G, Westermark P, Wernerson A, Herlenius G, Sletten K, Ericzon BG. Liver transplantation as rescue treatment in a patient with primary AL kappa amyloidosis. Transpl Int 2000;13:92-97.
29. McPherson RA, Onstad JW, Ugoretz RJ, Wolf PL. Coagulopathy in amyloidosis: combined deficiency of factors IX and X. Am J Hematol 1977;3:225-235.
30. Gatel A, Cacoub P, Piette JC. AL amyloidosis combined with acquired factor V deficiency. Ann Intern Med 1998;128:604-605.
31. Choufani EB, Sanchorawala V, Ernst T, et al. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood 2001;97:1885-1887.
32. Greipp PR, Kyle RA, Bowie EJ. Factor-X deficiency in amyloidosis: a critical review. Am J Hematol 1981;11:443-450.
33. Nakagawa S. Ultrastructural aspects of cell membrane in amyloidogenesis and amyloid fibril destruction. In: Glenner GG, Costa PP, Freitas AF, editors. Amyloid and amyloidosis. Proceedings of the Third International Symposium on Amyloidosis. Amsterdam: Excerpta Medica; 1980. p 436-447.
34. Comenzo RL, Vosburgh E, Falk RH, et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood 1998;91:3662-3670.
35. Pojda Z, Molineux G, Dexter TM. Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF. Exp Hematol 1990;18:27-31.
36. Molineux G, Pojda Z, Hampson IN, Lord BI, Dexter TM. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 1990;76:2153-2158.
37. Welte K, Boxer LA. Severe chronic neutropenia: pathophysiology and therapy. Semin Hematol 1997;34:267-278.
38. Nakayama T, Kudo H, Suzuki S, Sassa S, Mano Y, Sakamoto S. Splenomegaly induced by recombinant human granulocyte-colony stimulating factor in rats. Life Sci 2001;69:1521-1529.
39. Becker PS, Wagle M, Matous S, et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transpl 1997;3:45-49.
40. Falzetti F, Aversa F, Minelli O, Tabilio A. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet 1999;353:555.
41. Kasper C, Jones L, Fujita Y, Morgenstern GR, Scarffe JH, Chang J. Splenic rupture in a patient with acute myeloid leukemia undergoing peripheral blood stem cell transplantation. Ann Hematol 1999;78:91-92.